# Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

> **NCT01175759** · PHASE2 · UNKNOWN · sponsor: **EVE Medical Systems Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Abortion, Recurrent

## Interventions

- **DRUG:** Skin test panel
- **DRUG:** Skin test panel

## Key facts

- **NCT ID:** NCT01175759
- **Lead sponsor:** EVE Medical Systems Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175759, "Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01175759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*